UMG is advancing its data integration center and becomes the first German university hospital to introduce MDClone's internationally established ADAMS model.Göttingen, Germany and BEER-SHEVA, Israel, Sept. 28, 2026 /PRNewswire/ -- The University Medical Center Göttingen (UMG) is the…
PUNE, India, Sept. 25, 2026 /PRNewswire/ -- The Global AI in Clinical Trials Market was valued at USD 2 Billion in 2025 and is projected to grow at a 15.5% CAGR from 2026 to 2034, reaching USD 7.32 Billion…
PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Nanomedicine Market was valued at USD 207.91 Billion in 2025 and is projected to expand at a 12.1% CAGR from 2025 to 2034, reaching USD 581.2 Billion by 2034, according…
OKLAHOMA CITY, Sept. 22, 2026 /PRNewswire/ -- The University of Oklahoma today announced an historic $150 million gift from Harold Hamm, the largest single gift in university history, to lift the health of Oklahoma by advancing health education,…
90% freedom from atrial arrhythmias at six months with neuromodulation vs. 80.8% with shamRandomized, double-blind, sham-controlled results presented as late-breaking clinical science at HRX Live 2026 and simultaneously published in peer-reviewed Heart RhythmATLANTA and LOS ANGELES, Sept. 20,…
ROCHESTER, Mich., Sept. 18, 2026 /PRNewswire/ -- Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to…
MIAMI, Sept. 16, 2026 /PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, is expanding its distinct, structured approach to addressing postpartum depression (PPD) among women in correctional settings, where postpartum patients face heightened vulnerability and…
WASHINGTON, Sept. 16, 2026 /PRNewswire/ -- NSSF®, The Firearm Industry Trade Association, released its 2026 Congressional Report Card, grading sitting U.S. Representatives and U.S. Senators on key legislation that is of critical importance to the firearm industry, the…
DEEp SEA is a global Phase III trial evaluating efficacy, safety and tolerability of the investigational molecule bexicaserin in children and adults with Dravet syndrome1Completion of randomization marks another important milestone for the global Phase III DEEp program,…
New CoreJet™ integrated emitter technology and a redesigned nanoZero® union combine proven Aurora Series® performance with a step-change in robustness, lowering cost per sample without compromising the depth and sensitivity researchers depend on.MELBOURNE, Australia, Sept. 13, 2026 /PRNewswire/…